Clinical Trials Browser

Phase 2 × Kidney Neoplasms × pegfilgrastim × Clear all

NCT00068393 2023-07-07

Doxorubicin and Gemcitabine in Treating Patients With Locally Recurrent or Metastatic Unresectable Renal Cell Carcinoma

Phase 2 Completed

39 enrolled 7 charts

Carcinoma, Renal Cell, Kidney Neoplasms